Welcure Drugs & Pharmaceuticals Ltd Share Price

AGM Date: 12 Jul 2021

In terms of General Circular no. 02/2021 dated January 13, 2021 in continuation of General Circular No. 14/2020 dated April 08, 2020, Circular No.17/2020 dated April 13, 2020 and Circular No. 20/2020 dated May 05, 2020 issued by Ministry of Corporate Affairs read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed copies of Public notice regarding convening of 29th Annual General Meeting (AGM) through video conferencing ('VC'), Book Closure and E-voting related procedure of the Company published in newspaper viz. The Financial Express (English Newspaper) & JanSatta (Hindi Newspaper) on Wednesday, May 26, 2021. This is for your information and records. Pursuant to provisions of Regulation 30, 34 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with General Circular no. 02/2021 in continuation of General Circular No. 14/2020 dated April 08, 2020, Circular No.17/2020 dated April 13, 2020 and Circular No. 20/2020 dated May 05, 2020, that has enabled convening of the Annual General Meeting (AGM) through video conferencing or other audio visual means, we wish to inform you that, the 29th Annual General Meeting ('AGM') is scheduled to be held on Monday, July 12, 2021 at 10:00 A.M through Video Conferencing or other audio visual to transact businesses as set out in the Notice of AGM and no physical meeting will be held. This will ensure safety of the shareholders while providing an early opportunity to attend the AGM. The 29th Annual General Meeting (''AGM'') of Welcure Drugs and Pharmaceuticals Limited (''the Company'') was held today i.e. Monday, 12th July, 2021 at 10:00 A.M. through Video Conferencing / Other Audio Visual Means. The Proceedings of the Annual General Meeting is attached herewith. (As Per BSE Announcement dated on 12.07.2021) In continuation of our letter dated 12th July, 2021 regarding proceeding of 29th Annual General Meeting ('AGM') of Welcure Drugs & Pharmaceuticals Ltd ('the Company') held on Monday, 12th July, 2021 at 10:00 A.M. through Video Conferencing/other audio visual means, please find enclosed herewith the voting results (for E-Voting) along with the Scrutinizer's Report, as per the provision of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records. The 29th Annual General Meeting (''''AGM'''') of Welcure Drugs and Pharmaceuticals Limited (''''the Company'''') was held today i.e. Monday, 12th July, 2021 at 10:00 A.M. through Video Conferencing / Other Audio Visual Means. The Proceedings of the Annual General Meeting is attached herewith. (As per BSE Announcement Dated on 12/7/2021) Welcure Drugs & Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (AS Per BSE Announcement Dated on 13.07.2021)

AGM Date: 27 Jun 2022

AGM 27/06/2022 Pursuant to provisions of Regulation 30, 34 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,circular dated 5th May, 2020 read with circulars dated 8th April, 2020, 13th April, 2020, 15th June, 2020, 28th September, 2020, 31st December, 2020, 13th January, 2021, 23rd June, 2021 and December 8, 2021 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Circular dated January 15, 2021 and May 12, 2020, that has enabled convening of the Annual General Meeting through video conferencing or other audio visual means, we wish to inform you that, the 30th Annual General Meeting is scheduled to be held on Monday, 27th June, 2022 at 10:00 A.M through Video Conferencing or other audio visual to transact businesses as set out in the Notice of AGM and no physical meeting will be held. In terms of Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find attached herewith the Annual Report for financial year ended March 31, 2022. The Company will provide its members with facility to cast their vote(s) on all resolutions as stated in Notice by remote e-voting during the Annual General Meeting. The e-voting instructions and the process to join meeting through video conferencing is set out in Notice, which forms part of the Annual Report. (As Per BSE Announcement dated on 26.05.2022) In terms of General circular dated 5th May, 2020 read with circulars dated 8th April, 2020, 13th April, 2020, 15th June, 2020, 28th September, 2020, 31st December, 2020, 13th January, 2021, 23rd June, 2021 and December 8, 2021 issued by Ministry of Corporate Affairs read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed copies of Public notice regarding convening of 30th Annual General Meeting (AGM) through video conferencing ('VC'), Book Closure and E-voting related procedure of the Company published in newspaper viz. The Financial Express (English Newspaper) & JanSatta (Hindi Newspaper) on Saturday, May 28, 2022. This is for your information and records. (As per BSE Announcement Dated on 28.05.2022) The 30th Annual General Meeting ('AGM') of Welcure Drugs and Pharmaceuticals Limited (the 'Company') was held today i.e. Monday, 27th June, 2022 at 10:00 A.M. through Video Conferencing or other audio visual means. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we submit proceedings of the 30th AGM of the Company. This is for your information and records. (As Per BSE Announcement Dated on 27/06/2022) In continuation of our letter dated 27th June, 2022 regarding proceeding of 30th Annual General Meeting ('AGM') of Welcure Drugs & Pharmaceuticals Ltd ('the Company') held on Monday, 27th June, 2022 at 10:00 A.M. through Video Conferencing/other audio visual means, please find enclosed herewith the voting results (for E-Voting) along with the Scrutinizer's Report, as per the provision of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records. (As Per BSE Announcement Dated on 28.06.2022) Welcure Drugs & Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 29/06/2022)

AGM Date: 28 Sep 2023

the outcome of the Board Meeting held today i.e. on Monday, 04 Sept, 2023 at 04.30 P.M and concluded at 6.00 P.M at the registered office of the Company.1.The Board considered and approved Financial Statement, Notice of 31st AGM and Director''s Report of the Company 2.The Board appointed Mr. Vivek Kumar as the Scrutinizer for the purpose of 31st Annual General Meeting.3.The Board appointed Mr. Manish Guptaas Internal Auditor of the company for the financial year 2023-24.4. The Board considered the Resignation of M/s V. P. Gupta & Co. from the post of Statutory Auditor etc Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. We hereby submit the proceedings of 31st AGM of the Company. which was held today i.e, Thursday, 28th September, 2023 at 12:30 P.M. through Video Conferencing or other audio video means. (As Per BSE Announcement dated on 28.09.2023) The 31st AGM of the Company was held on Thursday, 28th September, 2023 at 12:30 P.M through Video Conferencing mode. We are hereby submitting the copy of Scrutinizer''s Report. (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Outcome of Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited (As per BSE Announcement Dated on 02/09/2024) Proceedings of 32nd AGM held on 30th September, 2024. (As Per Bse Announcement Dated on 30.09.2024) Voting Results as per Regulation 44 of SEBI (LODR) Regulations, 2015 of the 32nd AGM of the company held on 30th September, 2024. (As Per BSE Announcement Dated on: 01/10/2024)

AGM Date: 27 Sep 2025

AGM 27/09/2025 Meeting of the Board of Directors of the Company, duly convened and held at the registered office of the Company i.e. Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi India, 110092, on Tuesday, 02nd September, 2025 at 02:00 P.M. (i.e., 1400 Hours) and concluded at 4.15 P.M (i.e., 1615 Hours) Outcome of the AGM of the company (As Per BSE Announcement Dated on: 27/09/2025) Voting Results of 33rd Annual General Meeting of Welcure Pharmaceutical Limited held on 27th September, 2025. (As Per BSE Announcement Dated on 30.09.2025)